Dr Humera (Meena) Khan PhD, MSc, BSc (Hons)

 

Programme Manager

Primary Care Clinical Sciences

HumeraKhan-Cropped-110x146

Contact details

Primary Care Clinical Sciences
School of Health and Population Sciences
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

About

Meena Khan is the programme manager on the PARTNERS2 project, developing a system of collaborative care for people with severe mental illness, providing management to members of the research team, particularly research fellows, associates and assistants, and closely liaising with the site PIs and MHRN/PCRN leads. She is responsible for the co-ordination the six workstreams across three different sites (Birmingham. Lancashire and Devon), ensuring compliance with all regulatory and administrative requirements

Qualifications

  • PhD in Genetic Epidemiology, University of Birmingham
  • MSc in Genetic Epidemiology, University of Sheffield
  • BSc (Hons) in Microbiology, University of Leeds

Biography

After completing an MSc in Genetic Epidemiology at the University of Sheffield, Meena started a PhD in the department of Public Health, Epidemiology and Biostatistics at the University of Birmingham. She set up the Birmingham Prostatic Neoplasms Association Study (BiPAS) as part of her PhD, investigating the determinants of prostate cancer. She investigated the role of a number of environmental and genetic risk factors in the disease. She then went on to manage a large cohort study looking at bladder cancer recurrence and progression. She joined the Primary Care department in May 2011 and worked on a number of randomized controlled trials investigating hypertension, stroke prevention and more recently in mental health.

Research

Meena is currently the programme manager for the NIHR funded PARTNERS2 programme. For more details, please see: http://www.birmingham.ac.uk/partners2

Publications

Bryan RT, Zeegers MP, van Roekel EH, Bird D, Grant MR, Dunn JA, Bathers S, Begum G, Khan HS, Collins SI, Howman A, Deshmukh NS, James ND, Cheng KK, Wallace DMA. A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU Int. 2013 Jul;112(2):169-75

Zeegers MP, Nekeman D, Khan HS, van Dijk BAC, Goldbohm RA, Schalken J, Shajahan S, Pearlman A, Oddoux C, van den Brandt PA, Schouten LJ, Ostrer H. Prostate cancer susceptibility genes on 8p21-23 in a Dutch population Prostate Cancer Prostatic Dis. 2013;Sept:16:248-253

Khan HS, Zeegers MP, Schouten LJ, van Dijk BAC, Goldbohm RA, Schalken J, Shajahan S, Pearlman A, Oddoux C, van den Brandt PA, Ostrer H (2011) Association between genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population, European Journal of Human Genetics, 19 (1):118-20

Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dörk T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan HS, Slavov C, Mitkova A, Cao G; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF (2009), Identification of seven new prostate cancer susceptibility loci through a genome-wide association study, Nature Genetics, 41 (10): 1116-21

Back to top